allogeneic fibroblast cells

**Allogeneic fibroblast cells** are a donor-derived cell therapy consisting of cultured fibroblasts, typically administered locally such as by intradermal injection or topical application to promote tissue repair. In published clinical and translational literature, this term most commonly refers to experimental fibroblast cell therapy for wound healing, especially in **recessive dystrophic epidermolysis bullosa**, where exogenous fibroblasts are intended to secrete extracellular matrix components and paracrine mediators that enhance repair and can increase type VII collagen expression at the dermal-epidermal junction. The therapeutic concept is regenerative rather than receptor-targeted: the cells act through matrix production, trophic signaling, and modulation of the wound microenvironment. However, the exact product is **not a single uniquely defined commercial drug**, because \"allogeneic fibroblast cells\" can describe multiple investigational products made by different groups for wound healing, scarring, burns, diabetic ulcers, and related regenerative applications.

Other names

allogeneic fibroblastscultured allogeneic fibroblastsintradermal allogeneic fibroblasts